Lyra Therapeutics, Inc.

Q1 2023 13F Holders

Symbol
LYRA
CUSIP
55234L105
Type
Equity
Class
COM
Num filings
34
Total reported value, excl. options
$38.1 M
Manager Report Date Value ($000) Shares Option Type